IP Library Granted Patent US 11,759,638
Granted Patent B2
US 11,759,638 · App. 17/552,005 · Granted Sep 19, 2023

Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods

Inventors: Konstantinos Alataris (Belmont, CA); Andre B. Walker (Monte Sereno, CA); Jon Parker (Portland, OR)
Assignee: Nevro Corp.
A61N1/36071A61N1/3615A61N1/36021A61N1/36132A61N1/36171A61N1/36178A61N1/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,759,638
App. No.
17/552,005
Granted
Sep 19, 2023
Kind
B2
Abstract

Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods are disclosed. A representative method in accordance with an embodiment of the disclosure includes creating a therapeutic effect and a sensation in a patient by delivering to the patient first pulses having a first set of first signal delivery parameters and second pulses having a second set of second signal delivery parameters, wherein a first value of at least one first parameter of the first set is different than a second value of a corresponding second parameter of the second set, and wherein the first pulses, the second pulses or both the first and second pulses are delivered to the patient's spinal cord.

Claims (31)

1. A method for configuring a patient treatment system to deliver therapy to a target neural population at a patient's spinal cord, the method comprising:

programming a signal generator of the patient treatment system to:

generate bursts of low frequency pulses comprising at least one pair of pulses, wherein the at least one pair of pulses has a frequency in a frequency range of from 2 Hz to 1.2 kHz;

generate a paresthesia-free electrical signal having sequential bi-phasic pulses with a pulse width in a pulse width range of from 10 microseconds to 333 microseconds; and

deliver the bursts of low frequency pulses and the paresthesia-free electrical signal to the target neural population in cycles.

2. The method of claim 1 wherein the pulse width range is from 25 microseconds to 166 microseconds.

3. The method of claim 1 wherein each bi-phasic pulse of the paresthesia-free electrical signal has an anodic phase and a cathodic phase, and wherein at least one of the anodic phase and the cathodic phase has the pulse width in the pulse width range of from 10 microseconds to 333 microseconds.

4. The method of claim 1 wherein the sequential bi-phasic pulses of the paresthesia-free electrical signal have a frequency in a frequency range of from 1.5 kHz to 100 kHz.

5. The method of claim 1 wherein the sequential bi-phasic pulses of the paresthesia-free electrical signal have a frequency in a frequency range of from 5 kHz to 15 kHz.

6. The method of claim 1 wherein each low frequency pulse has a pulse width in a pulse width range of from 10 microseconds to 1,000 microseconds.

7. The method of claim 1 wherein the bursts of low frequency pulses induce paresthesia in the patient.

8. The method of claim 1 wherein, within the cycles, the low frequency pulses of the bursts of low frequency pulses do not temporally overlap with the pulses of the paresthesia-free electrical signal.

9. The method of claim 1 wherein each individual cycle of the cycles includes a burst of at least three low frequency pulses and a burst of the bi-phasic pulses of the paresthesia-free electrical signal.

10. The method of claim 1 , wherein programming the signal generator includes programming the signal generator to direct the bursts of low frequency pulses to a first electrode of the patient treatment system and the paresthesia-free electrical signal to a second electrode of the patient treatment system different than the first electrode.

11. The method of claim 1 wherein programming the signal generator includes programming the signal generator to direct the bursts of low frequency pulses and the paresthesia-free electrical signal to a common electrode of the patient treatment system.

12. A patient treatment system, comprising:

an implantable signal delivery device having a plurality of electrodes designed to be implanted within a patient's epidural space, proximate to one or more target neural populations of the patient's spinal cord; and

a pulse generator electrically coupleable to the implantable signal delivery device, wherein, in operation, the pulse generator:

generates bursts of low frequency pulses comprising at least one pair of pulses, wherein the at least one pair of pulses has a frequency in a frequency range of from 2 Hz to 1.2 kHz,

generates a paresthesia-free electrical signal having sequential bi-phasic pulses with a pulse width in a pulse width range of from 10 microseconds to 333 microseconds, and

delivers the bursts of low frequency pulses and the paresthesia-free electrical signal to the target neural population via the implantable signal delivery device in cycles.

13. The system of claim 12 wherein, in operation, the pulse generator directs the bursts of low frequency pulses to a first electrode of the plurality of electrodes and the paresthesia-free electrical signal to a second electrode of the plurality of electrodes different than the first electrode.

14. The system of claim 12 wherein, in operation, the pulse generator directs the bursts of low frequency pulses and the paresthesia-free electrical signal to a common electrode of the plurality of electrodes.

15. The system of claim 12 wherein the pulse width range is from 25 microseconds to 166 microseconds.

16. The system of claim 12 wherein each bi-phasic pulse of the paresthesia-free electrical signal has an anodic phase and a cathodic phase, and wherein at least one of the anodic phase and the cathodic phase has the pulse width in the pulse width range of from 10 microseconds to 333 microseconds.

17. The system of claim 12 wherein the sequential bi-phasic pulses of the paresthesia-free electrical signal have a frequency in a frequency range of from 1.5 kHz to 100 kHz.

18. The system of claim 12 wherein the sequential bi-phasic pulses of the paresthesia-free electrical signal have a frequency in a frequency range of from 5 kHz to 15 kHz.

19. The system of claim 12 wherein each low frequency pulse has a pulse width in a pulse width range of from 10 microseconds to 1,000 microseconds.

20. The system of claim 12 wherein the bursts of low frequency pulses induce paresthesia in the patient.

21. The system of claim 12 wherein, within the cycles, the low frequency pulses of the bursts of low frequency pulses do not temporally overlap with the pulses of the paresthesia-free electrical signal.

22. The system of claim 12 wherein each individual cycle of the cycles includes a burst of at least three low frequency pulses and a burst of the bi-phasic pulses of the paresthesia-free electrical signal.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2021
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON
To: NEVRO CORP.
Reel/Frame 058401/0058 →
Continuity (5)
Continuation 16670712 · Oct 31, 2019
Continuation 14292671 · May 30, 2014
Continuation 12765685 · Apr 22, 2010
Provisional Application 61171790 · Apr 22, 2009
Related Publication 20220105343A1 · Apr 7, 2022
Cited By (6)
US 12,280,256 US 12,285,611 US 12,390,645 US 12,465,776 US 12,491,365 US 12,558,547